Hypomethylation and overexpression of ITGAL (CD11a) in CD4+ T cells in systemic sclerosis

Clinical Epigenetics

Volumn 6, Issue 1, 2014, Pages

  Wang, YaoYao ^a,b   Shu, Ye ^c   Xiao, YangFan ^a   Wang, Qing ^a   Kanekura, Takuro ^d   Li, YaPing ^a   Wang, JiuCun ^e   Zhao, Ming ^a,f   Lu, QianJin ^a,f   Xiao, Rong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c HUNAN CHILDREN'S HOSPITAL   (China)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e FUDAN UNIVERSITY   (China)

^f Hunan Key Laboratory of Medical Epigenomics   (China)

Author keywords

CD11a; CD4+ T cells; COL1A2; DNA methylation; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; AZACITIDINE; CHINESE DRUG; COLLAGEN TYPE 1; DNA; IMMUNOGLOBULIN G; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEPREDNISONE; MESSENGER RNA; MONOCLONAL ANTIBODY; PREDNISONE;

ADULT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DEMETHYLATION; DISEASE ACTIVITY; DNA METHYLATION; DNA MODIFICATION; EFFECTOR CELL; EPIGENETICS; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION;

EID: 84927514937     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-6-25     Document Type: Article

References (48)

1. Chizzolini C, Brembilla NC, Montanari E, Truchetet ME: Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 2011, 10: 276-281.
2. Cutolo M, Sulli A, Smith V: Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010, 6: 578-587.
3. Postlethwaite AE, Shigemitsu H, Kanangat S: Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 2004, 16: 733-738.
4. Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME: The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008, 38: 132-160.
5. O’Reilly S, Hügle T, van Laar JM: T cells in systemic sclerosis: a reappraisal. Rheumatology (Oxford) 2012, 51: 1540-1549.
6. Chizzolini C: T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr Opin Rheumatol 2008, 20: 707-712.
7. Shimaoka M, Springer TA: Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2003, 2: 703-716.
8. Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ: Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 2002, 22: 146-167.
9. Stummvoll GH, Aringer M, Grisar J, Steiner CW, Smolen JS, Knobler R, Graninger WB: Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis 2004, 63: 569-574.
10. Manetti M, Neumann E, Müller A, Schmeiser T, Saar P, Milia AF, Endlicher E, Roeb E, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L, Müller-Ladner U: Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis. Arthritis Rheum 2008, 58: 2866-2873.
11. Gruschwitz MS, Hornstein OP, von Den DP: Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995, 38: 184-189.
12. Sawaya HH, de Souza RB, Carrasco S, Goldenstein-Schainberg C: Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations. Clin Rheumatol 2009, 28: 847-851.
13. Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G III, Gerber ML, Jimenez SA, Seibold JR, Koch AE: The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford) 2009, 48: 734-740.
14. Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, Muroi E, Hara T, Ogawa F, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S: Cell adhesion molecules regulate fibrotic process via Th1/Th2/ Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 2010, 185: 2502-2515.
15. Luo Y, Wang Y, Wang Q, Xiao R, Lu Q: Systemic sclerosis: genetics and epigenetics. J Autoimmun 2013, 41: 161-167.
16. Feghali-Bostwick C, Medsger TA Jr, Wright TM: Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003, 48: 1956-1963.
17. Broen JC, Radstake TR, Rossato M: The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 2014, 10(11): 671-681.
18. De Santis M, Selmi C: The therapeutic potential of epigenetics in autoimmune diseases. Clin Rev Allergy Immunol 2012, 42: 92-101.
19. Meda F, Folci M, Baccarelli A, Selmi C: The epigenetics of autoimmunity. Cell Mol Immunol 2011, 8: 226-236.
20. Selmi C, Feghali-Bostwick CA, Lleo A, Lombardi SA, De Santis M, Cavaciocchi F, Zammataro L, Mitchell MM, Lasalle JM, Medsger T Jr, Gershwin ME: X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma. Clin Exp Immunol 2012, 169: 253-262.
21. Lu Q, Ray D, Gutsch D, Richardson B: Effect of DNA methylation and chromatin structure on ITGAL expression. Blood 2002, 99: 4503-4508.
22. Richardson BC, Powers D, Hooper F, Yung RL, O’Rourke K: Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 1994, 37: 1363-1372.
23. Yung R, Powers D, Johnson K, Amento E, Carr D, Laing T, Yang J, Chang S, Hemati N, Richardson B: Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngeneic mice. J Clin Invest 1996, 97: 2866-2871.
24. Lu Q: The critical importance of epigenetics in autoimmunity. J Autoimmun 2013, 41: 1-5.
25. Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B: Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004, 172: 3652-3661.
26. Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q: Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009, 38: 369-374.
27. Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y, Wang Y, Yang Y, Zhao M, Lu Q: DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 2012, 64: 2338-2345.
28. Jiang H, Xiao R, Lian X, Kanekura T, Luo Y, Yin Y, Zhang G, Yang Y, Wang Y, Zhao M, Lu Q: Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin Immunol 2012, 143: 39-44.
29. Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, Richardson B: Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002, 46: 1282-1291.
30. Shelley CS, Farokhzad OC, Arnaout MA: Identification of cell-specific and developmentally regulated nuclear factors that direct myeloid and lymphoid expression of the CD11a gene. Proc Natl Acad Sci U S A 1993, 90: 5364-5368.
31. Puig-Kröger A, Sanchez-Elsner T, Ruiz N, Andreu EJ, Prosper F, Jensen UB, Gil J, Erickson P, Drabkin H, Groner Y, Corbi AL: RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 2003, 102: 3252-3261.
32. Domínguez-Soto A, Relloso M, Vega MA, Corbí AL, Puig-Kröger A: RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. Immunobiology 2005, 210: 133-139.
33. Cornwell RD, Gollahon KA, Hickstein DD: Description of the leukocyte function-associated antigen 1 (LFA-1 or CD11a) promoter. Proc Natl Acad Sci U S A 1993, 90: 4221-4225.
34. Lai AY, Mav D, Shah R, Grimm SA, Phadke D, Hatzi K, Melnick A, Geigerman C, Sobol SE, Jaye DL, Wade PA: DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B cell activation. Genome Res 2013, 23: 2030-2041.
35. Jintaridth P, Tungtrongchitr R, Preutthipan S, Mutirangura A: Hypomethylation of Alu elements in post-menopausal women with osteoporosis. PLoS One 2013, 8: e70386.
36. Mehra S, Walker J, Patterson K, Fritzler MJ: Autoantibodies in systemic sclerosis. Autoimmun Rev 2013, 12: 340-354.
37. Holland J, Owens T: Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line: the activation of Lyn tyrosine kinase and the mitogen-activated protein kinase pathway. J Biol Chem 1997, 272: 9108-9112.
38. Tohma S, Hirohata S, Lipsky PE: The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation. J Immunol 1991, 146: 492-499.
39. Cliff JM, Klaus GG: A method for investigating the role of homotypic adhesion in lymphocyte activation. J Immunol Methods 2000, 246: 51-59.
40. Carrasco YR, Fleire SJ, Cameron T, Dustin ML, Batista FD: LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity 2004, 20: 589-599.
41. López-Hoyos M, Revilladagger C, Conde C, Del Campo EG, González A, Merino J: Different roles for LFA-1 and VLA-4 integrins in T-B-cell interactions in vivo. Immunology 1999, 97: 438-446.
42. Arana E, Vehlow A, Harwood NE, Vigorito E, Henderson R, Turner M, Tybulewicz VL, Batista FD: Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation. Immunity 2008, 28: 88-99.
43. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senécal JL: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfoldcapillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001, 44: 735-736.
44. Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, Arimitsu J, Narazaki M, Hagihara K, Ogata A, Katayama I, Kawase I, Kishimoto T, Tanaka T: The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizuma. Rheumatology (Oxford) 2010, 49: 2408-2412.
45. Hudson M, Steele R, Baron M, Canadian Scleroderma Research Group (CSRG): Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum 2007, 37: 93-98.
46. Zhou Y, Yuan J, Pan Y, Fei Y, Qiu X, Hu N, Luo Y, Lei W, Li Y, Long H, Sawalha AH, Richardson B, Lu Q: T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 2009, 132: 362-370.
47. Xiao R, Yoshida N, Higashi Y, Lu QJ, Fukushige T, Kanzaki T, Kanekura T: Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts. J Dermatol 2011, 38: 345-353.
48. Ueda-Hayakawa I, Hasegawa M, Hamaguchi Y, Takehara K, Fujimoto M: Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. J Dermatol Sci 2013, 69: 54-60.